Evidence map›Paper›PMID 35707148›Full record

ArticleACS medicinal chemistry letters2022

Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups.

Andrew K Ecker, Dorothy A Levorse, Daniel A Victor, Matthew J Mitcheltree

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Accessing sulfonamides via formal SONature chemistry · 2025
    Article
  6. An Electrosynthesis of 1,3,4-Oxadiazoles from N-Acyl Hydrazones.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Design, Synthesis, and Evaluation of Novel ΔJournal of medicinal chemistry · 2023
    Article
  13. RSC advances · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew K EckerDepartment of Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115-5727, United States.ORCID https://orcid.org/0000-0001-7331-0825
Dorothy A LevorseDepartment of Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Daniel A VictorDepartment of Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Matthew J MitcheltreeDepartment of Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115-5727, United States.ORCID https://orcid.org/0000-0003-3774-628X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polar molecular surface area provides a valuable metric when optimizing properties as varied as membrane permeability and efflux susceptibility. The EPSA method to measure this quantity has had a substantial impact in medicinal chemistry, providing insight into the conformational and stereoelectronic features that govern the polarity of small molecules, targeted protein degraders, and macrocyclic peptides. Recognizing the value of bioisosteres in replacing permeation-limiting polar groups, we determined the effects of common amide, carboxylic acid, and phenol bioisosteres on EPSA, using matched molecular pairs within the Merck compound collection. Our findings reinforce EPSA's utility in optimizing permeability, highlight bioisosteres within each class that are particularly effective in lowering EPSA and others, which despite widespread use, offer little to no such benefit. Our method for matched-pair identification is generalizable across large compound collections and, thus, may constitute a flexible platform to study the effects of bioisosterism both in EPSA and other in vitro assays.

Identifiers

PMID35707148
PMCPMC9190035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.